News
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss: Our Bureau, Bengaluru Wednesday, July 30, 2025, 17:45 Hrs [IST] Physicians Committ ...
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...
Zydus Wellness posts net sales of Rs. 8,577 million in Q1FY26: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:15 Hrs [IST] Reporting its first quarter results for FY 26, Zydus We ...
SPPSPTM hosts Orientation Programme 2025 to welcome future pharma professionals: Our Bureau, Mumbai Wednesday, July 30, 2025, 17:30 Hrs [IST] The induction programme 2025 for new ...
MAIA Biotechnology receives US FDA fast track designation for ateganosine for the treatment of non-small cell lung cancer: Chicago Wednesday, July 30, 2025, 17:00 Hrs [IST] MAIA B ...
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify: Our Bureau, Mumbai Wednesday, July 30, 2025, 16:50 Hrs [IST] Rockwell Automatio ...
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT: Our Bureau, Bengaluru Wednesday, July 30, 2025, 10:45 Hrs [IST] Strides Pharma Sc ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results